Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
MERUS LABS Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MPH HEALTH CARE | 17,850 | -0,56 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
18.09.2025 / 16:25 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 12,150 | +3,89 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of... ► Artikel lesen | |
AMARIN | 15,500 | 0,00 % | Amarin Corporation plc: Amarin Reports Second Quarter 2025 Financial Results | -- European Partnership with Recordati Established to Maximize VAZKEPA® in Europe; Global Corporate Restructuring Implemented with Anticipated $70 Million in Operating Expense Savings Over Next 12... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,730 | +5,49 % | Sellas Life Sciences files to sell 19.69M shares of common stock for holders | ||
CATALYST PHARMACEUTICALS | 18,000 | +2,59 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals | CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
MADRIGAL PHARMACEUTICALS | 376,80 | +1,92 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | CONSHOHOCKEN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated... ► Artikel lesen | |
ANI PHARMACEUTICALS | 78,00 | +0,65 % | ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance | Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1% on a reported basis and 37.0% on an organic basisTotal Rare Disease quarterly net revenues of... ► Artikel lesen | |
DOGECOIN CASH | - | - | Dogecoin Cash, Inc.: Dogecoin Cash Inc. (OTCQB:DOGP) Announces Special Distribution of DogeCoin Cash (MEMECOIN:DOG) to Shareholders | MESQUITE, NV, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV - Dogecoin Cash Inc. (OTCQB:DOGP) today announced that its Board of Directors has approved a special distribution of DogeCoin Cash (MEMECOIN:DOG)... ► Artikel lesen | |
ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2026 ended June 30, 2025 and Provides Conference Call Information | Northvale, New Jersey--(Newsfile Corp. - August 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
BLUM HOLDINGS | - | - | Blum Holdings Inc. Reports First Quarter 2025 Financial Results | DOWNEY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Blum Holdings, Inc. (OTCQB: BLMH) (the "Company," "Blüm," "Blüm Holdings," "we" or "us"), a California-based publicly traded holding company and cannabis... ► Artikel lesen | |
BMP PHARMA TRADING | 4,900 | 0,00 % | PTA-News: B.M.P. Pharma Trading AG: Konzern weiterhin auf Erfolgskurs - Die Gesellschaft steigert das operative Halbjahresergebnis im Geschäftsjahr 2025 | DJ PTA-News: B.M.P. Pharma Trading AG: Konzern weiterhin auf Erfolgskurs - Die Gesellschaft steigert das operative Halbjahresergebnis im Geschäftsjahr 2025
Unternehmensmitteilung für den Kapitalmarkt... ► Artikel lesen | |
THERIVA BIOLOGICS | 0,461 | 0,00 % | Theriva Biologics, Inc.: Theriva Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT) | - Preclinical data for VCN-12, the next candidate from Theriva's VCN-X discovery program, highlight a novel mechanism of action with the potential to significantly improve antitumor effects -
-... ► Artikel lesen | |
KAZIA THERAPEUTICS | 7,170 | 0,00 % | Kazia Therapeutics Limited: Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program | SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration... ► Artikel lesen | |
ALLERGY THERAPEUTICS | 0,088 | -1,13 % | Allergy Therapeutics - Grass MATA MPL Publications in Allergy Journal | ||
ACURA PHARMACEUTICALS | - | - | ACURA PHARMACEUTICALS, INC - 8-K, Current Report |